References
- Menzies D., Ellis H. Intestinal obstruction from adhesion: how big is the problem ? Ann R Coll Surg Engl, 1990, 72: 60–63.
- Weibel M., Majno G. Peritoneal adhesions and their relationship to abdominal surgery. Am J Surg, 1973, 126: 345–353.
- Luijendijk R. W., Lange D. C., Wauters C. C. et al. Foreign material in postoperative adhesions. Ann Surg, 1996, 223: 242248.
- Ellis H., Moran B. J., Thompson J. N. et al. Adhesion related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet, 1999, 353: 1476–1480.
- DeCherney A. H., diZerega G. S. Clinical problem of peritoneal adhesion formation following general surgery and the use of adhesion prevention barriers. Clin North Am, 1997, 77: 671–688.
- Ivarsson M. L., Holmdahl L., Franzen G. et al. The cost of bowel obstruction resulting from adhesions. Eur J Surg, 1997, 163: 679684.
- Ellis H. Internal over healing: the problem of intraperitoneal adhesions. World J Surg, 1980, 4: 303–306.
- Reijnen M. M., Bleichrodt R. P., Van Goor H. Pathophysiology of intra-abdominal adhesion and abscess formation, and the effect of hyaluronan. Br J Surg, 2003, 90: 533–541.
- Gupta S., Jain P. K. Low-dose heparin in experimental peritonitis. Eur Surg Res, 1985, 17: 167–172.
- Turkcapar A. G., Ozarslan C., Erdem E. et al. The effectiveness of low molecular weight heparin on adhesion formation in an experimental rat model. Int Surg, 1995, 80: 92–94.
- SahinY., Saglam A. Synergistic effects of carboxymethylcellulose and low molecular weight heparin in reducing adhesion formation in the rat uterine horn model. Acta Obstet Gynecol Scand, 1994, 73: 70–73.
- Tayyar M., Basbug M. The effects of intraperitoneal piroxicam and low molecular weight heparin in the prevention of adhesion reformation in rat uterine horn. Res Exp Med (Berl), 1999, 198: 269–275.
- Arikan S., Adas G., Barut G. et al. An evaluation of low molecular weight heparin and hyperbaric oxygen treatment in the prevention of intra-abdominal adhesions and wound healing. Am J Surg, 2005, 189: 155–160.
- Menzies D., Ellis H. The role of plasminogen activator in adhesion prevention. Surg Gynecol Obstet, 1991, 172: 362–5.
- Evans D. M., McAree K., Daniel P. et al. Dose dependency and wound healing aspects of the use of tissue plasminogen activator in the prevention of intra-abdominal adhesions. Am J Surg, 1993, 165: 229–232.
- Esmon C. T. The role of activated protein C in maintaining homeostasis and its relevance to critical illness. Crit Care, 2001, 5: 7–12.
- Fulcher C. A., Gardiner J. E., Griffin J. H. et al. Proteolytic inac-tivation of human factor Viii procoagulant protein by activated human protein C and its analogy with factor V. Blood, 1984, 89: 534–540.
- Joyce D. E., Gelbert L., Ciaccia A. et al. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem, 2001, 276: 1119911203.
- Liebman S. M., Langer J. C., Marshall J. S. et al. Role of mast cells in peritoneal adhesion formation. Am J Surg, 1993, 165: 127130.
- Ar’Rajab A., Dawidson I., Sentementes J. et al. Enhancement of peritoneal macrophages reduces postoperative peritoneal adhesion formation. J Surg Res, 1995, 58: 307–312.
- Hong-Shiee L. A. I., Chen Y., Chang K. J. et al. Effects of octreotide on epidermal growth factor receptor, tissue plasminogen activator, and plasminogen activator inhibitor during intra-peritoneal adhesion formation. J Gastroenterol, 2003, 38: 555560.
- Raftery A. T. Effect of peritoneal trauma on peritoneal fibrinolytic activity and intraperitoneal adhesion formation. Eur Surg Res, 1981, 13: 397–401.
- Vipond M. N., Whawell S. A., Thompson J. N. et al. Peritoneal fibrinolytic activity and intra-abdominal adhesions. Lancet, 1990, 335: 1120–1122.
- Bakkum E. A., Emeis J. J., Dalmeijer R. A. et al. Long-term analysis of peritoneal plasminogen activator activity and adhesion formation after surgical trauma in the rat model. Fertil Steril, 1996, 66: 1018–1022.
- Whawell S. A., Vipond M. N., Scott-Coombes D. M. et al. Plasminogen activator inhibitor 2 reduces peritoneal activity in inflammation. Br J Surg, 1993, 80: 107–109.
- Yan S. B., Grinnell B. W. Antithrombotic and anti-inflammatory agents of Protein C anticoagulant pathway. Ann Rep Med Chem, 1994, 11: 103–112.
- Yilmazlar T., Kaya E., Gurpinar E., Emiroglu H. Efficacy of tenoxicam on intra-abdominal adhesion prevention in a rat model. J Int Med Res, 1996, 24: 352–357.